Christine A. Pellizzari

Insider Reports History

Identity 1 identity field
Location
Lawrenceville, NJ
SEC source record 1 source field
Owner filing signature
/s/ Susan Eylward, Attorney-in-Fact for Christine Pellizzari
Source evidence 1 source field

Reported holdings for Christine A. Pellizzari

Form 4 holding Chief Legal Officer

INSMED Inc

Security class
Common Stock
Shares / value
149,985
Estimated value
$4,294,071
Report date
15 May 2021
Price
$28.63
Ownership
Direct
Form 4 holding Chief Legal Officer

INSMED Inc

Security class
Stock Option (right to buy)
Shares / value
57,200
Estimated value
$1,172,028
Report date
12 May 2021
Price
$20.49
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Legal and HR Officer

Science 37 Holdings, Inc.

Security class
Common Stock
Shares / value
0
Estimated value
$0
Report date
12 Mar 2024
Price
$5.75
Ownership
Direct
Form 4 holding Chief Legal and HR Officer

Science 37 Holdings, Inc.

Security class
Restricted Stock Units
Shares / value
0
Estimated value
$0
Report date
12 Mar 2024
Price
$0.4085
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Imunon, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
4,827
Estimated value
Report date
02 Jan 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Legal and HR Officer

Science 37 Holdings, Inc.

Security class
Earn-Out Right
Shares / value
0
Estimated value
Report date
12 Mar 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Christine A. Pellizzari

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .